ecancermedicalscience

Review

Anal canal cancer in Brazil: why should we pay more attention to the epidemiology of this rare disease?

7 May 2020
Mauro DS Donadio, Rachel P Riechelmann

Anal canal cancer is one of the human papilloma virus (HPV)-associated diseases with increasing incidence. High-risk sexual behaviour and the resurgence of human immunodeficiency virus (HIV) infection, associated with low HPV vaccine coverage, are risk factors for the increased incidence of this cancer. In this paper, the authors point out pertinent questions regarding the greater exposure of the population to some risk factors and discuss the latest epidemiological data of these factors, particularly those of concern to emerging countries like Brazil. The authors also discuss policies adopted that have not been successful to combat the HIV and HPV rise and that have direct consequences on the incidence of anal canal cancer.

Related Articles

María Valeria Jiménez-Báez, Sofía Concepción Thomas-Gómez, Gabriel González-Guerrero, David Rojano-Mejía, Eduardo Patricio Achurra-Godinez
Berthe Sabine Esson Mapoko, Etienne Atenguena, Abdel Nasser Nsangou Moun, Esther Dina Bell, Lionel Tabola, Dominique Anaba, Anne Sango, Rachel Tayou
Liudmila Castelo David, Teresa Mota Garcia, Isaulina Barreto, Esperança Carvalho, Laurinda Barreto, Clara Aleydis, Laurinda Coelho, Lúcio Lara Santos
Priya Ranganathan, Manju Sengar, Aparna Mittal, Vivek Tomar, Girish Chinnaswamy, C S Pramesh
Tsion Zebdiwos Chema, Edom Seife Woldetsadik, Girum Tessema Zingeta, Hawi Furgassa Bedada, Mohammed Ibrahim Adem, Jilcha Diribi Feyisa, Winini Belay, Mushonga Melinda, K S Han Kathy, Rebecca Wong, Munir Awol, Bargude Balta